Post Covid-19 Elderly
Conditions
Brief summary
Participants had randomly divided into two equal groups. Group (A) which is the study group will receive photobiomodulation session two times per week for four weeks. Group (B) will be the control group that will receive placebo photobiomodulation two times per week for four weeks.
Detailed description
group (A): 1. Each participant will sign a consent form after receiving a detailed explanation about the procedure. 2. submaximal exercise capacity using time up and go test will be assessed. 3. fatigability will be assessed using fatigue assessment scale. 4. hemodynamic variables including; Blood pressure, heart rate, oxygen saturation, maximum oxygen consumption will also be assessed. 5. After one month all the assessment procedure will be repeated again. r group (B): 1. Each participant will sign a consent form after receiving a detailed explanation about the procedure. 2. submaximal exercise capacity using time up and go test will be assessed. 3. fatigability will be assessed using fatigue assessment scale. 4. hemodynamic variables including; Blood pressure, heart rate, oxygen saturation, maximum oxygen consumption will also be assessed. 5. After one month all the assessment procedure will be repeated again.
Interventions
RADIATIONphotobiomodulation
Photobiomodulation (PBM) describes the use of red or near-infrared light to stimulate, heal, regenerate, and protect tissue that has either been injured, is degenerating, or else is at risk of dying.
OTHERplacebo intervention by photobiomodulation device
placebo intervention while the photobiomodulation device is on the off mode
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Masking description
participants
Intervention model description
participants will divided into two equal groups , group A will receive photobiomodulation sessions and group B will receive placebo photobiomodulation
Eligibility
Sex/Gender
ALL
Age
60 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* 60 to 75 years of age * past history of covid 19 in the last year
Exclusion criteria
* ( history of a histologically demonstrated malignant carcinoma , hyperthyreosis , epilepsy, light sensitivity )
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| effect of photobiomodulation on fatigability level | after one month of the trial application | fatigability level will be assessed using fatigability assesment scale |
| effect of photobiomodulation on functional capacity level | after one month of the trial application | functional capacity state will be assessed using submaximal exercise test (time up and go test) |
Countries
Egypt
Contacts
Primary ContactRana H El Banna, PHD
Backup ContactSherif O Elabd, master
Outcome results
None listed